
Sign up to save your podcasts
Or


Dr Woyach discusses new clinical data with BTK inhibitors in both chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/965742?src=mkm_podcast_addon_965742
By Medscape4.3
2525 ratings
Dr Woyach discusses new clinical data with BTK inhibitors in both chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/965742?src=mkm_podcast_addon_965742

135 Listeners

695 Listeners

496 Listeners

170 Listeners

101 Listeners

885 Listeners

13 Listeners

17 Listeners

291 Listeners

260 Listeners

3,332 Listeners

1,153 Listeners

195 Listeners

90 Listeners

513 Listeners

365 Listeners

172 Listeners

61 Listeners

8 Listeners

432 Listeners